Phase 1 Multiple Ascending Dose Study of Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Mitapivat (AG-348) in Subjects with Sickle Cell Disease
暂无分享,去创建一个
J. Nichols | E. Henry | W. Eaton | C. Kung | L. Dang | Emily B. Dunkelberger | S. Thein | Varsha Iyer | Troy Cellmer | N. Jeffries | P. Kosinski | Laxminath Tumburu | Anna K Conrey | J. Xu | L. Menapace | I. Frey | T. Lequang | Quan Li | P. Hawkins | H. Mangus